Sumi E - Search Results

1

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.

Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, Inoue N, Shibuya M, Okamoto N, Mitsuishi T, Uozumi R, Tada H, Nakagawa T, Kusuba N, Okuno A, Shimizuhira C, Ishikawa M, Tanaka S, Hagiwara M, Kabashima K. Nomura T, et al. Among authors: sumi e. JID Innov. 2021 May 20;1(3):100026. doi: 10.1016/j.xjidi.2021.100026. eCollection 2021 Sep. JID Innov. 2021. PMID: 34909725 Free PMC article. Clinical Trial.

2

The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial.

Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, Uozumi R, Tada H, Nakagawa T, Hagiwara M, Kabashima K. Nomura T, et al. Among authors: sumi e. Trials. 2019 Aug 9;20(1):489. doi: 10.1186/s13063-019-3570-6. Trials. 2019. PMID: 31399147 Free PMC article.

3

Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts.

Sumi E, Nomura T, Asada R, Uozumi R, Tada H, Amino Y, Sawada T, Yonezawa A, Hagiwara M, Kabashima K. Sumi E, et al. Clin Drug Investig. 2019 Jan;39(1):55-61. doi: 10.1007/s40261-018-0712-7. Clin Drug Investig. 2019. PMID: 30284700 Free PMC article. Clinical Trial.

4

Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial.

Ikeda HO, Muraoka Y, Hata M, Sumi E, Ikeda T, Nakagawa T, Abe H, Tada H, Morita S, Kakizuka A, Yoshimura N, Tsujikawa A. Ikeda HO, et al. Among authors: sumi e. PLoS One. 2020 Feb 13;15(2):e0229068. doi: 10.1371/journal.pone.0229068. eCollection 2020. PLoS One. 2020. PMID: 32053676 Free PMC article. Clinical Trial.

5

CDK9 Inhibitor FIT-039 Suppresses Viral Oncogenes E6 and E7 and Has a Therapeutic Effect on HPV-Induced Neoplasia.

Ajiro M, Sakai H, Onogi H, Yamamoto M, Sumi E, Sawada T, Nomura T, Kabashima K, Hosoya T, Hagiwara M. Ajiro M, et al. Among authors: sumi e. Clin Cancer Res. 2018 Sep 15;24(18):4518-4528. doi: 10.1158/1078-0432.CCR-17-3119. Epub 2018 Apr 30. Clin Cancer Res. 2018. PMID: 29712686

6

Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer.

Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka Y, Hamazaki Y, Minato N, Toi M. Sugie T, et al. Among authors: sumi e. Breast. 2018 Apr;38:114-119. doi: 10.1016/j.breast.2017.12.017. Epub 2018 Jan 5. Breast. 2018. PMID: 29310035 Clinical Trial.

7

The increase in prescriptions of bisphosphonates and the incidence proportion of osteonecrosis of the jaw after risk communication activities in Japan: a hospital-based cohort study.

Sumi E, Yamazaki T, Tanaka S, Yamamoto K, Nakayama T, Bessho K, Yokode M. Sumi E, et al. Pharmacoepidemiol Drug Saf. 2014 Apr;23(4):398-405. doi: 10.1002/pds.3562. Epub 2014 Jan 8. Pharmacoepidemiol Drug Saf. 2014. PMID: 24399628 Free PMC article.

8

Risk factors and indices of osteomyelitis of the jaw in osteoporosis patients: results from a hospital-based cohort study in Japan.

Yamazaki T, Yamori M, Tanaka S, Yamamoto K, Sumi E, Nishimoto-Sano M, Asai K, Takahashi K, Nakayama T, Bessho K. Yamazaki T, et al. Among authors: sumi e. PLoS One. 2013 Nov 1;8(11):e79376. doi: 10.1371/journal.pone.0079376. eCollection 2013. PLoS One. 2013. PMID: 24223935 Free PMC article.

9

Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol.

Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N. Sumi E, et al. J Transl Med. 2014 Nov 25;12:310. doi: 10.1186/s12967-014-0310-2. J Transl Med. 2014. PMID: 25421542 Free PMC article. Clinical Trial.

10

An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital.

Ito-Ihara T, Hong JH, Kim OJ, Sumi E, Kim SY, Tanaka S, Narita K, Hatta T, Choi EK, Choi KJ, Miyagawa T, Minami M, Murayama T, Yokode M. Ito-Ihara T, et al. Among authors: sumi e. BMC Med Res Methodol. 2013 Oct 25;13:130. doi: 10.1186/1471-2288-13-130. BMC Med Res Methodol. 2013. PMID: 24156760 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page